Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 31st, there was short interest totaling 1,282,116 shares, an increase of 67.4% from the March 15th total of 765,827 shares. Approximately 20.3% of the company’s stock are sold short. Based on an average daily trading volume, of 5,967,409 shares, the short-interest ratio is currently 0.2 days.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in LABD. Simplex Trading LLC bought a new position in shares of Direxion Daily S&P Biotech Bear 3x Shares in the fourth quarter worth approximately $48,000. Envestnet Asset Management Inc. bought a new position in shares of Direxion Daily S&P Biotech Bear 3x Shares in the second quarter worth approximately $84,000. Quadrature Capital Ltd bought a new position in shares of Direxion Daily S&P Biotech Bear 3x Shares in the fourth quarter worth approximately $245,000. Csenge Advisory Group bought a new position in shares of Direxion Daily S&P Biotech Bear 3x Shares in the third quarter worth approximately $271,000. Finally, JPMorgan Chase & Co. lifted its position in Direxion Daily S&P Biotech Bear 3x Shares by 655.9% during the third quarter. JPMorgan Chase & Co. now owns 6,803 shares of the company’s stock valued at $275,000 after purchasing an additional 5,903 shares during the period.
Direxion Daily S&P Biotech Bear 3x Shares Trading Down 5.7%
Shares of NYSEARCA LABD traded down $0.89 during midday trading on Monday, hitting $14.71. The stock had a trading volume of 6,403,689 shares, compared to its average volume of 4,018,272. The business’s 50 day moving average is $18.26 and its 200-day moving average is $22.93. Direxion Daily S&P Biotech Bear 3x Shares has a 52 week low of $14.15 and a 52 week high of $111.50.
About Direxion Daily S&P Biotech Bear 3x Shares
The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion.
See Also
Receive News & Ratings for Direxion Daily S&P Biotech Bear 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bear 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
